Clariane stock rebounds above its €3.11 support level and gains 2.5%
The group of specialized retirement homes and home care services rebounds after a session that saw it briefly dip below a closely monitored technical threshold. It benefits from a stable Paris market, as its quarterly revenue is published today.
A support level breached then recovered during the session, ahead of third-quarter revenue
Clariane is trading at €3.23 and gaining 2.54% compared to the previous day (€3.15). The stock initially broke its €3.11 support level to touch a low of €3.10, before rising back above it and closing the gap. This recovery comes as the Clariane group publishes its third-quarter 2026 revenue today, following a decline of 17.18% over a month that had brought it to the lowest point of the past twelve months, as noted during its fall below €3.15 on October 22.
With a gain of 2.54%, the stock ranks among the notable gainers of the SBF 120 during the session.
A rebound that leaves the price far from its moving averages and balance sheet benchmarks
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The price remains below its three moving averages: 1.52% below the MA20 (€3.28), 12.23% below the MA50 (€3.68) and 16.97% below the MA200 (€3.89).
The RSI at 38 indicates a still weak configuration, without any reversal signal. Among comparable stocks, Emeis gains 2.59% today, but has lost 8.26% over one month and 25.66% over three months.
On the fundamental side, at the publication of H1 2026 results on July 29, 2026, the group targeted an improvement in its EBITDA margin of 100 to 150 basis points by end of 2026, while citing inflationary pressure on its operational costs among its risks. The revenue published today will help assess this trajectory.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 2 699 millions d'euros
Quarterly revenue: 2 699 millions d'euros
Revenue growth: 1,6 %
EBITDA: 524 millions d'euros
EBITDA margin: 10,4 %
Net income: -47,5 millions d'euros
Free cash flow: 20 millions d'euros
3 020 millions d'euros
Guidance from the release
Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
Environnement géopolitique complexe affectant les opérations de refinancement
Exposition aux épisodes climatiques frappant durement certains territoires en Europe
Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
Expected revenue: 5 522 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
